These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 2611526

  • 1. Preclinical studies on L-671,152, a topically effective ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS.
    Br J Pharmacol; 1989 Dec; 98 Suppl():820P. PubMed ID: 2611526
    [No Abstract] [Full Text] [Related]

  • 2. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF, Gautheron P, Mallorga P, Nolan TE, Graham SL, Schwam H, Shepard KL, Smith RL.
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of a topically administered carbonic anhydrase inhibitor (MK-927) in normotensive and glaucomatous beagles.
    King TC, Gum GG, Gelatt KN.
    Am J Vet Res; 1991 Dec; 52(12):2067-70. PubMed ID: 1789524
    [Abstract] [Full Text] [Related]

  • 4. Trusopt, a topical carbonic anhydrase inhibitor.
    Donohue EK, Wilensky JT.
    J Glaucoma; 1996 Feb; 5(1):68-74. PubMed ID: 8795737
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
    Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS.
    Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
    [Abstract] [Full Text] [Related]

  • 6. [A new topical carbonic anhydrase inhibitor (MK-927). Tolerance comparison with betaxolol in healthy probands].
    Feicht B, Hofmann HM, Lippa E, Brunner-Ferber F, von Denffer H, Merté HJ.
    Klin Monbl Augenheilkd; 1990 Sep; 197(3):254-7. PubMed ID: 2255169
    [Abstract] [Full Text] [Related]

  • 7. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors.
    Brechue WF, Maren TH.
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2581-7. PubMed ID: 8325759
    [Abstract] [Full Text] [Related]

  • 8. [Successful pressure decrease and improved patient quality of life by Trusopt].
    Prell R.
    Klin Monbl Augenheilkd; 1996 Apr; 208(4):11-2. PubMed ID: 8778487
    [No Abstract] [Full Text] [Related]

  • 9. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Gautheron P, Grove J, Mallorga P, Viader MP, Schwam H, Baldwin JJ, Christy ME, Ponticello GS.
    J Ocul Pharmacol; 1990 Apr; 6(1):9-22. PubMed ID: 2362161
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of the effectiveness of a mixture of 10% L-arginine and HCl combined with 0.5% Timoptol and with 2% Trusopt: and the individual components on intraocular pressure in an experiment on rabbits].
    Veselovský J, Oláh Z, Veselá A, Gressnerová S.
    Cesk Slov Oftalmol; 2004 May; 60(3):163-70. PubMed ID: 15307650
    [Abstract] [Full Text] [Related]

  • 11. [Local carbonic anhydrase inhibitor dorzolamide: development and properties].
    Pfeiffer N.
    Ophthalmologe; 1996 Feb; 93(1):103-18. PubMed ID: 8867167
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of twice daily application of 2% dorzolamide on intraocular pressure in normal cats.
    Rainbow ME, Dziezyc J.
    Vet Ophthalmol; 2003 Jun; 6(2):147-50. PubMed ID: 12753617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.
    Vanlandingham BD, Maus TL, Brubaker RF.
    Ophthalmology; 1998 Aug; 105(8):1537-40. PubMed ID: 9709770
    [Abstract] [Full Text] [Related]

  • 16. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.
    Maren TH, Bar-Ilan A, Conroy CW, Brechue WF.
    Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193
    [Abstract] [Full Text] [Related]

  • 17. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride].
    Egorov AE.
    Vestn Oftalmol; 1996 Jan; 112(2):3-4. PubMed ID: 9045485
    [Abstract] [Full Text] [Related]

  • 18. [Trusopt--a new form of drug for treating glaucoma].
    Izdebska J.
    Klin Oczna; 1997 Jan; 99(3):217-20. PubMed ID: 9456571
    [Abstract] [Full Text] [Related]

  • 19. The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeys.
    Wang RF, Serle JB, Podos SM, Surgrue MF.
    Curr Eye Res; 1990 Feb; 9(2):163-8. PubMed ID: 2335112
    [Abstract] [Full Text] [Related]

  • 20. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF, Maren TH.
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.